SIPrEP: A tool to monitor HIV pre-exposure prophylaxis in Spain
Carlos Iniesta, Julia del Amo(Government of Spain), Débora Álvarez-del Arco(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Olga Monteagudo-Piqueras(Servicio Murciano de Salud), Asunción Díaz(Instituto de Salud Carlos III), Santiago Camara(McGill University), J. de la Torre-Lima(Junta de Andalucía), Álvaro Torres Lana(Servicio Canario de la Salud), Josefina Belda, Henar Marcos(Junta de Castilla y León), Aitziber Echeverría(Instituto de Salud Pública de Navarra), Wafa Ben Cheikh(Gobierno de Aragón), Julián-Alexander Portocarrero-Núñez(Red de Investigación en Sida), Vicent Villanueva(Servicio Canario de la Salud), Víctoria Hernando(Instituto de Salud Carlos III), Maribel Soteras(Valencian International University), M. Mayorga(Hospital Regional Universitario de Málaga)
Cited by 3
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
|American Journal of Epidemiology|2019|116
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
|The Lancet Infectious Diseases|2021|104